Anneli Savinainen
About
In The Last Decade
Anneli Savinainen
24 papers receiving 585 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 223
- Immunology 183
- Surgery 174
- Oncology 107
- Cellular and Molecular Neuroscience 72
Countries citing papers authored by Anneli Savinainen
This map shows the geographic impact of Anneli Savinainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anneli Savinainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anneli Savinainen more than expected).
Fields of papers citing papers by Anneli Savinainen
This network shows the impact of papers produced by Anneli Savinainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anneli Savinainen. The network helps show where Anneli Savinainen may publish in the future.
Co-authorship network of co-authors of Anneli Savinainen
This figure shows the co-authorship network connecting the top 25 collaborators of Anneli Savinainen. A scholar is included among the top collaborators of Anneli Savinainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anneli Savinainen. Anneli Savinainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 3 | |
| 3 | Ocular distribution and exposure of AU-011 after suprachoroidal or intravitreal administration in an orthotopic rabbit model of human uveal melanoma | 5 |
| 4 | Ocular distribution and efficacy after suprachoroidal injection of AU-011 for treatment of ocular melanoma | 10 |
| 5 | Distribution of Aqueous Solutions Injected Suprachoroidally (SC) in Rabbits | 3 |
| 6 | 9 | |
| 7 | 13 | |
| 8 | 9 | |
| 9 | 12 | |
| 10 | 8 | |
| 11 | Reduction of intraocular pressure by SHP639, a novel C-type natriuretic peptide analog, and its exposure in aqueous humor of normotensive Dutch Belted rabbits and beagle dogs | 1 |
| 12 | 40 | |
| 13 | 27 | |
| 14 | RX-10001 (RvE1) an Endogenously Formed Immune Modulator Attenuates Clinical Signs of Autoimmune Disease in the Rat CIA Model Concurrent With Inhibition of T-Cell Dependent Cytokines in Mixed Cell Populations From Draining Lymph Nodes | 1 |
| 15 | Resolvin Analogs With Pharmacokinetic Properties Suitable for Topical Administration to Treat Ocular Diseases | 4 |
| 16 | 69 | |
| 17 | 16 | |
| 18 | 33 | |
| 19 | 100 | |
| 20 | 29 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.